SEMA4C and breast carcinoma: In support of this, Liu et al. demonstrated that SEMA4C expression is negatively regulated by miR-138, with the overexpression of miR-138 capable of inhibiting the invasive behaviour of breast cancer cells and reversing EMT features [42].